Pascal Reboul
Overview
Explore the profile of Pascal Reboul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Garo F, Reboul P, Gerbal M, Moranne O
J Nephrol
. 2023 Aug;
36(9):2649-2650.
PMID: 37578595
No abstract available.
3.
Gautam P, Maenner S, Cailotto F, Reboul P, Labialle S, Jouzeau J, et al.
Clin Transl Med
. 2022 Oct;
12(10):e1032.
PMID: 36245291
Psoriasis is a chronic inflammatory disorder affecting skin and joints that results from immunological dysfunction such as enhanced IL-23 induced Th-17 differentiation. IkappaB-Zeta (IκBζ) is an atypical transcriptional factor of...
4.
Cardinale A, Messikh Z, Antoine V, Aglae C, Reboul P, Cariou S, et al.
J Nephrol
. 2022 May;
35(8):2097-2108.
PMID: 35503200
Introduction: Acute Kidney Injury (AKI) is increasingly common in people over 65 years of age, but its causes and management are poorly described. The purpose of this study was to...
5.
Marques R, Sestito S, Bourgaud F, Miguel S, Cailotto F, Reboul P, et al.
Molecules
. 2022 Mar;
27(6).
PMID: 35335304
Bryophytes produce rare and bioactive compounds with a broad range of therapeutic potential, and many species are reported in ethnomedicinal uses. However, only a few studies have investigated their potential...
6.
Schulz C, Messikh Z, Reboul P, Cariou S, Ahmadpoor P, Pambrun E, et al.
J Nephrol
. 2022 Jan;
35(5):1375-1385.
PMID: 35028894
Introduction: Chronic kidney disease (CKD) affects > 10% of the population but not all CKD patients require referral to a nephrologist. Various recommendations for referral to nephrologists are proposed worldwide....
7.
Ahmadpoor P, Aglae C, Garo F, Cariou S, Renaud S, Reboul P, et al.
Int J Hematol
. 2020 Oct;
113(3):456-460.
PMID: 33067738
Acquired Immune thrombotic thrombocytopenic purpura (iTTP) is considered among clinical situations that needs not only urgent treatment in acute setting but also long term management to prevent relapses. Important progresses...
8.
Hablot J, Ferhat M, Lavelle A, Salem F, Taieb M, Medvedovic J, et al.
Clin Transl Med
. 2020 Sep;
10(5):e163.
PMID: 32997419
No abstract available.
9.
Ahmadpoor P, Aglae C, Cariou S, Pambrun E, Renaud S, Garo F, et al.
Ther Apher Dial
. 2020 Jul;
25(3):262-272.
PMID: 32710797
Nowadays, therapeutic plasmapheresis (TP) is accepted as part of the treatment for specific groups of diseases. The availability of different methods, including double filtration and adsorption, increases selectivity for the...
10.
Teisseyre M, Perrochia H, Reboul P, Cariou S, Renaud S, Aglae C, et al.
BMC Nephrol
. 2020 May;
21(1):196.
PMID: 32448215
Background: The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous...